Status:
COMPLETED
Ultrasound Guided Rhomboid Intercostal Block for Myofascial Pain Syndrome
Lead Sponsor:
Diskapi Teaching and Research Hospital
Conditions:
Myofascial Pain Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rhomboid intercostal block (RIB) is an interfacial plane block described in 2016. It creates analgesia at T2-T9 levels in the hemithorax by applying local anesthetic to the fascia between the rhomboid...
Detailed Description
Myofascial pain syndrome (MPS) is the most common cause of musculoskeletal pain and its prevalence in the population is reported to be 21-30%. Rhomboid intercostal block (RIB) is an interfacial plane ...
Eligibility Criteria
Inclusion
- Complaint of myofascial pain
- Pain that is rated at least 3 on a numerical rating scale (NRS, 0 = no pain, 10 = the worst pain)
Exclusion
- pregnancy
- the presence of coagulopathy, or the use of anticoagulants
- a history of surgery on the block area
- allergic to bupivacaine
- decline to participate
Key Trial Info
Start Date :
February 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 26 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04751110
Start Date
February 10 2021
End Date
April 26 2021
Last Update
November 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diskapi Yildirim Beyazit Training and Research Hospital
Ankara, Turkey (Türkiye), 06110